AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,000 | 0.0% | 485 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -99.9% | 485 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $9,993,000 | +60.2% | 432,803 | -2.0% | 0.10% | +28.0% |
| Q3 2020 | $6,237,000 | -8.2% | 441,709 | -1.9% | 0.08% | -13.7% |
| Q2 2020 | $6,792,000 | +33.3% | 450,376 | -18.3% | 0.10% | +5.6% |
| Q1 2020 | $5,096,000 | -9.8% | 551,501 | -5.0% | 0.09% | +20.0% |
| Q4 2019 | $5,652,000 | +15.1% | 580,299 | -5.2% | 0.08% | +8.7% |
| Q3 2019 | $4,910,000 | -8.8% | 612,278 | +42.0% | 0.07% | -15.9% |
| Q2 2019 | $5,382,000 | -9.2% | 431,218 | -1.0% | 0.08% | -13.7% |
| Q1 2019 | $5,925,000 | +23.0% | 435,689 | -13.4% | 0.10% | 0.0% |
| Q4 2018 | $4,819,000 | -21.6% | 502,983 | -1.0% | 0.10% | -4.0% |
| Q3 2018 | $6,143,000 | +33.9% | 508,133 | +73.0% | 0.10% | +32.0% |
| Q2 2018 | $4,588,000 | +2.8% | 293,712 | -1.1% | 0.08% | 0.0% |
| Q1 2018 | $4,465,000 | +4.3% | 296,891 | -0.2% | 0.08% | +2.7% |
| Q4 2017 | $4,279,000 | +3.2% | 297,349 | +8.1% | 0.07% | +5.8% |
| Q3 2017 | $4,148,000 | +7.0% | 275,060 | -28.5% | 0.07% | +3.0% |
| Q2 2017 | $3,876,000 | +36.9% | 384,955 | -3.0% | 0.07% | +26.4% |
| Q1 2017 | $2,831,000 | +43.5% | 397,025 | +0.0% | 0.05% | +39.5% |
| Q4 2016 | $1,973,000 | -42.2% | 396,951 | -14.0% | 0.04% | -40.6% |
| Q3 2016 | $3,415,000 | +33.5% | 461,446 | -1.5% | 0.06% | +20.8% |
| Q2 2016 | $2,559,000 | -27.4% | 468,708 | +12.3% | 0.05% | -32.1% |
| Q1 2016 | $3,527,000 | +62.4% | 417,435 | +86.5% | 0.08% | +52.9% |
| Q4 2015 | $2,172,000 | +18.9% | 223,875 | +71.6% | 0.05% | +15.9% |
| Q3 2015 | $1,826,000 | -33.2% | 130,490 | -32.5% | 0.04% | -29.0% |
| Q2 2015 | $2,734,000 | +28.1% | 193,235 | -1.5% | 0.06% | +26.5% |
| Q1 2015 | $2,135,000 | – | 196,235 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |